3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Classical hematology
1
Conditions
Neutropenia
1
Neoplasms
1
Hematologic Neoplasms
1
Fever
1
Febrile Neutropenia
1
Interventions
pegylated granulocyte colony-stimulating factor
3
pegfilgrastim
3
Vancomycin
3
Interleukin 1 Receptor Antagonist Protein
2
Filgrastim
2
Ceftazidime
2
Cefepime
2
Amikacin
2
Vaccination
1
Teicoplanin
1
Tazobactam
1
Surveys and Questionnaires
1
Sodium Chloride
1
Positron Emission Tomography Computed Tomography
1
Pneumococcal Vaccines
1
Piperacillin
1
N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid
1
Meropenem
1
Linezolid
1
Itraconazole
1
Injections
1
Cloxacillin
1
Ciprofloxacin
1
Cilastatin, Imipenem Drug Combination
1
Bevacizumab
1
Anti-Bacterial Agents
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Febrile Neutropenia
×
Cilastatin, Imipenem Drug Combination
×
Clear all
NCT02149329
2019-09-25
SHORT
Amsterdam UMC, location VUmc
Phase 4
Completed
276 enrolled